Moderna Inc.’s COVID-19 vaccine is effective in children and adolescents, with mostly mild to moderate side effects, the U.S. Food and Drug Administration staff said.
“Available data support the effectiveness of the Moderna Covid-19 vaccine in preventing symptomatic Covid-19 in pediatric age groups from 6 months through 17 years of age,” the FDA staff said Friday in the report posted to the agency’s website. Side effects were “mostly mild to moderate in severity, generally of short duration.”
The release of the report precedes a two-day meeting starting on June 14 where experts will weigh recommending clearance of the vaccine for use in those age groups.
